Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01461954 | FST-100 in the Treatment of Acute Viral Conjunctivitis | PHASE2 | COMPLETED | 132 | — | — | May 17, 2013 | Mar 10, 2014 | Jun 24, 2021 | 2 | United States, Brazil |
| Arm | Type | Description |
|---|---|---|
| FST-100 | EXPERIMENTAL | - |
| FST-100 Vehicle | PLACEBO_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| FST-100 | DRUG | FST-100 |
| FST-100 Vehicle | DRUG | FST-100 Vehicle |
Inclusion Criteria: * Have a clinical diagnosis of suspected acute viral conjunctivitis in at least one eye Exclusion Criteria: * Have a known sensitivity to any of the components of FST-100 or FST-100 vehicle